APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antibiotics Active Pharmaceutical Ingredient (API)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antibiotics Active Pharmaceutical Ingredient (API) Industry Growth and Trends Forecast to 2032

Report ID 173965710120 December 2025111 pages

Choose your research edition.

Industry ResearchAntibiotics Active Pharmaceutical Ingredient (API) Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Antibiotics Active Pharmaceutical Ingredient (API) Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Antibiotics Active Pharmaceutical Ingredient (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antibiotics Active Pharmaceutical Ingredient (API) Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Antibiotics Active Pharmaceutical Ingredient (API) Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Antibiotics Active Pharmaceutical Ingredient (API) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antibiotics Active Pharmaceutical Ingredient (API) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antibiotics Active Pharmaceutical Ingredient (API) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antibiotics Active Pharmaceutical Ingredient (API) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antibiotics Active Pharmaceutical Ingredient (API) include Zhejiang Jiuzhou Pharmaceutical, Shenzhen Haibin Pharmaceutical, Sandoz International, Nanjing Dorra Pharmaceutical Technology, Fresenius Kabi, Unimark Remedies, The United Laboratories International Holdings, Sterile India and Savior Lifetec, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antibiotics Active Pharmaceutical Ingredient (API) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antibiotics Active Pharmaceutical Ingredient (API) market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antibiotics Active Pharmaceutical Ingredient (API) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antibiotics Active Pharmaceutical Ingredient (API).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antibiotics Active Pharmaceutical Ingredient (API) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antibiotics Active Pharmaceutical Ingredient (API) Market by Company

Zhejiang Jiuzhou Pharmaceutical

Shenzhen Haibin Pharmaceutical

Sandoz International

Nanjing Dorra Pharmaceutical Technology

Fresenius Kabi

Unimark Remedies

The United Laboratories International Holdings

Sterile India

Savior Lifetec

Penam Laboratories

Parabolic Drugs

Kyongbo Pharm

DAEWOONG PHARMACEUTICAL

CordenPharma International

Centrient Pharmaceuticals

Aurobindo Pharma

ASIATIC DRUGS & PHARMACEUTICALS

ACS DOBFAR

Antibiotics Active Pharmaceutical Ingredient (API) Segment by Type

Penicillin Antibiotics

Carbapenem Antibiotics

Cephalosporins

Antibiotics Active Pharmaceutical Ingredient (API) Segment by Application

Contract Development & Manufacturing Organizations (CDMOs)

Contract Manufacturing Organizations (CMOs)

Pharmaceutical Companies

Antibiotics Active Pharmaceutical Ingredient (API) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antibiotics Active Pharmaceutical Ingredient (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antibiotics Active Pharmaceutical Ingredient (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antibiotics Active Pharmaceutical Ingredient (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antibiotics Active Pharmaceutical Ingredient (API) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antibiotics Active Pharmaceutical Ingredient (API) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Penicillin Antibiotics Table 2. Major Company of Carbapenem Antibiotics Table 3. Major Company of Cephalosporins Table 4. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (Tons) Table 6. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type (2021-2026) Table 9. Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2021-2026) & (US$/Ton) Table 10. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2027-2032) & (Tons) Table 11. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type (2027-2032) Table 14. Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Type (2027-2032) & (US$/Ton) Table 15. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (Tons) Table 16. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (Tons) Table 18. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (Tons) Table 22. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Type (2021-2026) & (US$ Million) Table 25. Antibiotics Active Pharmaceutical Ingredient (API) Industry Trends Table 26. Antibiotics Active Pharmaceutical Ingredient (API) Industry Drivers Table 27. Antibiotics Active Pharmaceutical Ingredient (API) Industry Opportunities and Challenges Table 28. Antibiotics Active Pharmaceutical Ingredient (API) Industry Restraints Table 29. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Antibiotics Active Pharmaceutical Ingredient (API) Revenue Market Share by Company (2021-2026) Table 31. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Company (2021-2026) & (Tons) Table 32. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Share by Company (2021-2026) Table 33. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Antibiotics Active Pharmaceutical Ingredient (API) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Antibiotics Active Pharmaceutical Ingredient (API) Major Company Production Sites and Headquarters Table 36. Global Antibiotics Active Pharmaceutical Ingredient (API) Company, Product Type & Application Table 37. Global Antibiotics Active Pharmaceutical Ingredient (API) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Antibiotics Active Pharmaceutical Ingredient (API) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2021-2026) & (Tons) Table 42. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Region (2021-2026) Table 45. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2027-2032) & (Tons) Table 47. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Region (2027-2032) Table 50. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (Tons) Table 53. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application (2021-2026) Table 56. Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2021-2026) & (US$/Ton) Table 57. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2027-2032) & (Tons) Table 58. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application (2027-2032) Table 61. Global Antibiotics Active Pharmaceutical Ingredient (API) Price by Application (2027-2032) & (US$/Ton) Table 62. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (Tons) Table 63. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (Tons) Table 65. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (Tons) Table 69. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Application (2021-2026) & (US$ Million) Table 72. Zhejiang Jiuzhou Pharmaceutical Company Information Table 73. Zhejiang Jiuzhou Pharmaceutical Business Overview Table 74. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 76. Zhejiang Jiuzhou Pharmaceutical Recent Development Table 77. Shenzhen Haibin Pharmaceutical Company Information Table 78. Shenzhen Haibin Pharmaceutical Business Overview Table 79. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 81. Shenzhen Haibin Pharmaceutical Recent Development Table 82. Sandoz International Company Information Table 83. Sandoz International Business Overview Table 84. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 86. Sandoz International Recent Development Table 87. Nanjing Dorra Pharmaceutical Technology Company Information Table 88. Nanjing Dorra Pharmaceutical Technology Business Overview Table 89. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 91. Nanjing Dorra Pharmaceutical Technology Recent Development Table 92. Fresenius Kabi Company Information Table 93. Fresenius Kabi Business Overview Table 94. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 96. Fresenius Kabi Recent Development Table 97. Unimark Remedies Company Information Table 98. Unimark Remedies Business Overview Table 99. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 101. Unimark Remedies Recent Development Table 102. The United Laboratories International Holdings Company Information Table 103. The United Laboratories International Holdings Business Overview Table 104. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 105. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 106. The United Laboratories International Holdings Recent Development Table 107. Sterile India Company Information Table 108. Sterile India Business Overview Table 109. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 110. Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 111. Sterile India Recent Development Table 112. Savior Lifetec Company Information Table 113. Savior Lifetec Business Overview Table 114. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 115. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 116. Savior Lifetec Recent Development Table 117. Penam Laboratories Company Information Table 118. Penam Laboratories Business Overview Table 119. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 120. Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 121. Penam Laboratories Recent Development Table 122. Parabolic Drugs Company Information Table 123. Parabolic Drugs Business Overview Table 124. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 125. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 126. Parabolic Drugs Recent Development Table 127. Kyongbo Pharm Company Information Table 128. Kyongbo Pharm Business Overview Table 129. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 130. Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 131. Kyongbo Pharm Recent Development Table 132. DAEWOONG PHARMACEUTICAL Company Information Table 133. DAEWOONG PHARMACEUTICAL Business Overview Table 134. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 135. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 136. DAEWOONG PHARMACEUTICAL Recent Development Table 137. CordenPharma International Company Information Table 138. CordenPharma International Business Overview Table 139. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 140. CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 141. CordenPharma International Recent Development Table 142. Centrient Pharmaceuticals Company Information Table 143. Centrient Pharmaceuticals Business Overview Table 144. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 145. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 146. Centrient Pharmaceuticals Recent Development Table 147. Aurobindo Pharma Company Information Table 148. Aurobindo Pharma Business Overview Table 149. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 150. Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 151. Aurobindo Pharma Recent Development Table 152. ASIATIC DRUGS & PHARMACEUTICALS Company Information Table 153. ASIATIC DRUGS & PHARMACEUTICALS Business Overview Table 154. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 155. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 156. ASIATIC DRUGS & PHARMACEUTICALS Recent Development Table 157. ACS DOBFAR Company Information Table 158. ACS DOBFAR Business Overview Table 159. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 160. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio Table 161. ACS DOBFAR Recent Development Table 162. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 163. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (Tons) Table 164. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2021-2026) Table 165. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032) & (Tons) Table 166. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Country (2027-2032) Table 167. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026) & (US$ Million) Table 169. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country (2021-2026) Table 170. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Share Forecast by Country (2027-2032) Table 172. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 173. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (Tons) Table 174. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2021-2026) Table 175. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032) & (Tons) Table 176. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Country (2027-2032) Table 177. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 178. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026) & (US$ Million) Table 179. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country (2021-2026) Table 180. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 181. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Share Forecast by Country (2027-2032) Table 182. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 183. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (Tons) Table 184. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2021-2026) Table 185. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032) & (Tons) Table 186. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Country (2027-2032) Table 187. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 188. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026) & (US$ Million) Table 189. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country (2021-2026) Table 190. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 191. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Share Forecast by Country (2027-2032) Table 192. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 193. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (Tons) Table 194. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2021-2026) Table 195. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032) & (Tons) Table 196. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Country (2027-2032) Table 197. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 198. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026) & (US$ Million) Table 199. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country (2021-2026) Table 200. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 201. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Share Forecast by Country (2027-2032) Table 202. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 203. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026) & (Tons) Table 204. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share by Country (2021-2026) Table 205. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032) & (Tons) Table 206. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share Forecast by Country (2027-2032) Table 207. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 208. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026) & (US$ Million) Table 209. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country (2021-2026) Table 210. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 211. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Share Forecast by Country (2027-2032) Table 212. Key Raw Materials Table 213. Raw Materials Key Suppliers Table 214. Antibiotics Active Pharmaceutical Ingredient (API) Distributors List Table 215. Antibiotics Active Pharmaceutical Ingredient (API) Customers List Table 216. Research Programs/Design for This Report Table 217. Authors List of This Report Table 218. Secondary Sources Table 219. Primary Sources List of Figures Figure 1. Antibiotics Active Pharmaceutical Ingredient (API) Image Figure 2. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size (2021-2032) & (US$ Million) Figure 4. Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (2021-2032) & (Tons) Figure 5. Penicillin Antibiotics Image Figure 6. Global Penicillin Antibiotics Sales YoY Growth (2021-2032) & (Tons) Figure 7. Carbapenem Antibiotics Image Figure 8. Global Carbapenem Antibiotics Sales YoY Growth (2021-2032) & (Tons) Figure 9. Cephalosporins Image Figure 10. Global Cephalosporins Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Type 2025 VS 2032 Figure 13. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type in 2025 Figure 14. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type in 2025 Figure 15. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Contract Development & Manufacturing Organizations (CDMOs) Image Figure 26. Global Contract Development & Manufacturing Organizations (CDMOs) Sales YoY Growth (2021-2032) & (Tons) Figure 27. Contract Manufacturing Organizations (CMOs) Image Figure 28. Global Contract Manufacturing Organizations (CMOs) Sales YoY Growth (2021-2032) & (Tons) Figure 29. Pharmaceutical Companies Image Figure 30. Global Pharmaceutical Companies Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Application 2025 VS 2032 Figure 33. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application in 2025 Figure 34. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application in 2025 Figure 35. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Market Share in Value by Application in 2025 Figure 43. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Antibiotics Active Pharmaceutical Ingredient (API) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Antibiotics Active Pharmaceutical Ingredient (API) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Penicillin Antibiotics
  • Carbapenem Antibiotics
  • Cephalosporins
Applications
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Contract Manufacturing Organizations (CMOs)
  • Pharmaceutical Companies
Companies covered
  • Zhejiang Jiuzhou Pharmaceutical
  • Shenzhen Haibin Pharmaceutical
  • Sandoz International
  • Nanjing Dorra Pharmaceutical Technology
  • Fresenius Kabi
  • Unimark Remedies
  • The United Laboratories International Holdings
  • Sterile India
  • Savior Lifetec
  • Penam Laboratories
  • Parabolic Drugs
  • Kyongbo Pharm
  • DAEWOONG PHARMACEUTICAL
  • CordenPharma International
  • Centrient Pharmaceuticals
  • Aurobindo Pharma
  • ASIATIC DRUGS & PHARMACEUTICALS
  • ACS DOBFAR

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antibiotics Active Pharmaceutical Ingredient (API) Market by Type
  6. 1.3.1 Penicillin Antibiotics
  7. 1.3.2 Carbapenem Antibiotics
  8. 1.3.3 Cephalosporins
  9. 1.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Type
  10. 1.4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antibiotics Active Pharmaceutical Ingredient (API) Industry Trends
  2. 2.2 Antibiotics Active Pharmaceutical Ingredient (API) Industry Drivers
  3. 2.3 Antibiotics Active Pharmaceutical Ingredient (API) Industry Opportunities and Challenges
  4. 2.4 Antibiotics Active Pharmaceutical Ingredient (API) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antibiotics Active Pharmaceutical Ingredient (API) Revenue (2021-2026)
  2. 3.2 Global Top Players by Antibiotics Active Pharmaceutical Ingredient (API) Sales (2021-2026)
  3. 3.3 Global Top Players by Antibiotics Active Pharmaceutical Ingredient (API) Price (2021-2026)
  4. 3.4 Global Antibiotics Active Pharmaceutical Ingredient (API) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antibiotics Active Pharmaceutical Ingredient (API) Major Company Production Sites & Headquarters
  6. 3.6 Global Antibiotics Active Pharmaceutical Ingredient (API) Company, Product Type & Application
  7. 3.7 Global Antibiotics Active Pharmaceutical Ingredient (API) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antibiotics Active Pharmaceutical Ingredient (API) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antibiotics Active Pharmaceutical Ingredient (API) Tier 1, Tier 2, and Tier 3
4 Antibiotics Active Pharmaceutical Ingredient (API) Regional Status and Outlook
  1. 4.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Size by Region
  3. 4.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Market Size by Region
  7. 4.3.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antibiotics Active Pharmaceutical Ingredient (API) by Application
  1. 5.1 Antibiotics Active Pharmaceutical Ingredient (API) Market by Application
  2. 5.1.1 Contract Development & Manufacturing Organizations (CDMOs)
  3. 5.1.2 Contract Manufacturing Organizations (CMOs)
  4. 5.1.3 Pharmaceutical Companies
  5. 5.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Application
  6. 5.2.1 Global Antibiotics Active Pharmaceutical Ingredient (API) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Antibiotics Active Pharmaceutical Ingredient (API) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Antibiotics Active Pharmaceutical Ingredient (API) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zhejiang Jiuzhou Pharmaceutical
  2. 6.1.1 Zhejiang Jiuzhou Pharmaceutical Company Information
  3. 6.1.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
  4. 6.1.3 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zhejiang Jiuzhou Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  6. 6.1.5 Zhejiang Jiuzhou Pharmaceutical Recent Developments
  7. 6.2 Shenzhen Haibin Pharmaceutical
  8. 6.2.1 Shenzhen Haibin Pharmaceutical Company Information
  9. 6.2.2 Shenzhen Haibin Pharmaceutical Business Overview
  10. 6.2.3 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Shenzhen Haibin Pharmaceutical Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  12. 6.2.5 Shenzhen Haibin Pharmaceutical Recent Developments
  13. 6.3 Sandoz International
  14. 6.3.1 Sandoz International Company Information
  15. 6.3.2 Sandoz International Business Overview
  16. 6.3.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sandoz International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  18. 6.3.5 Sandoz International Recent Developments
  19. 6.4 Nanjing Dorra Pharmaceutical Technology
  20. 6.4.1 Nanjing Dorra Pharmaceutical Technology Company Information
  21. 6.4.2 Nanjing Dorra Pharmaceutical Technology Business Overview
  22. 6.4.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  24. 6.4.5 Nanjing Dorra Pharmaceutical Technology Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Unimark Remedies
  32. 6.6.1 Unimark Remedies Company Information
  33. 6.6.2 Unimark Remedies Business Overview
  34. 6.6.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  36. 6.6.5 Unimark Remedies Recent Developments
  37. 6.7 The United Laboratories International Holdings
  38. 6.7.1 The United Laboratories International Holdings Company Information
  39. 6.7.2 The United Laboratories International Holdings Business Overview
  40. 6.7.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  42. 6.7.5 The United Laboratories International Holdings Recent Developments
  43. 6.8 Sterile India
  44. 6.8.1 Sterile India Company Information
  45. 6.8.2 Sterile India Business Overview
  46. 6.8.3 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Sterile India Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  48. 6.8.5 Sterile India Recent Developments
  49. 6.9 Savior Lifetec
  50. 6.9.1 Savior Lifetec Company Information
  51. 6.9.2 Savior Lifetec Business Overview
  52. 6.9.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  54. 6.9.5 Savior Lifetec Recent Developments
  55. 6.10 Penam Laboratories
  56. 6.10.1 Penam Laboratories Company Information
  57. 6.10.2 Penam Laboratories Business Overview
  58. 6.10.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  60. 6.10.5 Penam Laboratories Recent Developments
  61. 6.11 Parabolic Drugs
  62. 6.11.1 Parabolic Drugs Company Information
  63. 6.11.2 Parabolic Drugs Business Overview
  64. 6.11.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  66. 6.11.5 Parabolic Drugs Recent Developments
  67. 6.12 Kyongbo Pharm
  68. 6.12.1 Kyongbo Pharm Company Information
  69. 6.12.2 Kyongbo Pharm Business Overview
  70. 6.12.3 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Kyongbo Pharm Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  72. 6.12.5 Kyongbo Pharm Recent Developments
  73. 6.13 DAEWOONG PHARMACEUTICAL
  74. 6.13.1 DAEWOONG PHARMACEUTICAL Company Information
  75. 6.13.2 DAEWOONG PHARMACEUTICAL Business Overview
  76. 6.13.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  78. 6.13.5 DAEWOONG PHARMACEUTICAL Recent Developments
  79. 6.14 CordenPharma International
  80. 6.14.1 CordenPharma International Company Information
  81. 6.14.2 CordenPharma International Business Overview
  82. 6.14.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 CordenPharma International Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  84. 6.14.5 CordenPharma International Recent Developments
  85. 6.15 Centrient Pharmaceuticals
  86. 6.15.1 Centrient Pharmaceuticals Company Information
  87. 6.15.2 Centrient Pharmaceuticals Business Overview
  88. 6.15.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  90. 6.15.5 Centrient Pharmaceuticals Recent Developments
  91. 6.16 Aurobindo Pharma
  92. 6.16.1 Aurobindo Pharma Company Information
  93. 6.16.2 Aurobindo Pharma Business Overview
  94. 6.16.3 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aurobindo Pharma Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  96. 6.16.5 Aurobindo Pharma Recent Developments
  97. 6.17 ASIATIC DRUGS & PHARMACEUTICALS
  98. 6.17.1 ASIATIC DRUGS & PHARMACEUTICALS Company Information
  99. 6.17.2 ASIATIC DRUGS & PHARMACEUTICALS Business Overview
  100. 6.17.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  102. 6.17.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Developments
  103. 6.18 ACS DOBFAR
  104. 6.18.1 ACS DOBFAR Company Information
  105. 6.18.2 ACS DOBFAR Business Overview
  106. 6.18.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient (API) Product Portfolio
  108. 6.18.5 ACS DOBFAR Recent Developments
7 North America by Country
  1. 7.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  2. 7.1.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026)
  4. 7.1.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
  6. 7.2.1 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026)
  8. 7.2.3 North America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  2. 8.1.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026)
  4. 8.1.3 Europe Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
  6. 8.2.1 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  2. 9.1.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
  6. 9.2.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  2. 10.1.1 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026)
  4. 10.1.3 South America Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
  6. 10.2.1 South America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026)
  8. 10.2.3 South America Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country
  2. 11.1.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country
  6. 11.2.1 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antibiotics Active Pharmaceutical Ingredient (API) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antibiotics Active Pharmaceutical Ingredient (API) Value Chain Analysis
  2. 12.1.1 Antibiotics Active Pharmaceutical Ingredient (API) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antibiotics Active Pharmaceutical Ingredient (API) Production Mode & Process
  7. 12.2 Antibiotics Active Pharmaceutical Ingredient (API) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antibiotics Active Pharmaceutical Ingredient (API) Distributors
  10. 12.2.3 Antibiotics Active Pharmaceutical Ingredient (API) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst